RE: IPF market2 Mar 2020 12:34
I clicked through to the link that Aim helpfully provided on the NXP002 patent & was amazed to see its potential uses outside of fibrotic treatment, this caught my eye:
"It has been reported that tranilast has the ability to induce or enhance neurogenesis and, therefore, could be used as an agent to treat neuronal conditions such as .... multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer'"'"'s disease..."